Ebola Vaccine Produces Immune Response In 20 Phase 1 Study Participants

November 29, 2014 9:20 PM

14 0

An experimental Ebola vaccine produced immune responses in all 20 patients it was tested on.

"The unprecedented scale of the current Ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines, which may play a role in bringing this epidemic to an end and undoubtedly will be critically important in preventing future large outbreaks," said NIAID Director Anth...

Read more

To category page